Severe hypoglycemia multiplies death risk up to fourfold in diabetes, Novo Nordisk finds
admin 15th September 2017 Uncategorised 0LISBON, Portgal—Drugmaker after drugmaker has touted data showing next-gen diabetes meds lower hypoglycemia risks—and new studies from Novo Nordisk show why. Type 2 diabetes patients who suffer severe hypoglycemia are four times more likely to die within 15 days—and twice as likely to die, period.
More: Severe hypoglycemia multiplies death risk up to fourfold in diabetes, Novo Nordisk finds
Source: fierce